Occult Hepatitis C virus in the liver-transplanted patients received anti-HCV therapy

Occult Hepatitis C virus in the liver-transplanted patients received anti-HCV therapy - Occult Hepatitis C virus in the liver-transplanted patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026117

Enrollment

Registered

2017-02-14

Start date

2017-01-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis C virus infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who who will visit as outpatient or be admitted to Nagasaki university hospital. 2. Patients who were re-infected with HCV after liver transplantation or had been received anti-HCV therapy. 3. Patients not youger than 20 years old (at the time of informed consent) 4. Genders do not matter. 5. Patients providing written informed consent with their own will.

Exclusion criteria

Exclusion criteria: 1. Patients who were judged to be inappropriate for this study.

Design outcomes

Primary

Measure	Time frame
To detect occult HCV infection in the liver tissue and PBMC from the liver-transplanted patients who received anti-HCV therapy	—

Countries

Japan

Contacts

Public ContactSatoshi Miuma

Nagasaki University Hospital Department of Gastroenterology and Hepatology

miuma1002@gmail.com095-819-7481

Outcome results